Heart Failure With Preserved Ejection Fraction: Will Cardiac Magnetic Imaging Impact on Diagnosis, Treatment, and Outcomes?: Explaining the Need for Advanced Imaging to Clinical Stakeholders.

Clinicians frequently equate symptoms of volume overload to heart failure (HF) but such generalization may preclude diagnostic or etiologic precision essential to optimizing outcomes. HF itself must be specified as the disparate types of cardiac pathology have been traditionally surmised by examination of left ventricular (LV) ejection fraction (EF) as either HF with preserved LVEF (HFpEF-LVEF >50%) or reduced LVEF of (HFrEF-LVEF <40%). More recent data support a third, potentially transitional HF subtype, but therapy, assessment, and prognosis have been historically dictated within the corresponding LV metrics determined by echocardiography. The present effort asks whether this historically dominant role of echocardiography is now shifting slightly, becoming instead a shared if not complimentary test. Will there be a gradual increasing profile for cardiac magnetic resonance as the attempt to further refine our understanding, diagnostic accuracy, and outcomes for HFpEF is attempted?

Fragmentación mecánica y trombólisis guiada por catéter en la embolia pulmonar de riesgo intermedio / Mechanical fragmentation and catheter-guided thrombolysis in intermediate risk pulmonary embolism

La tromboembolia pulmonar aguda (TEPA) sigue siendo una importante causa de morbilidad y mortalidad a nivel mundial. Su diagnóstico, estratificación de riesgo y tratamiento precoz son fundamentales, siendo su pilar la anticoagulación. En pacientes de bajo riesgo cardiovascular, el pronóstico es excelente y solo basta con la administración de anticoagulantes. No obstante, debido al pobre pronóstico de los pacientes con riesgo elevado (descompensación hemodinámica), el enfoque terapéutico es más agresivo, utilizándose trombolíticos sistémicos que disminuyen la mortalidad pero incrementan el riesgo de complicaciones hemorrágicas mayores. En el TEPA de riesgo intermedio (evidencia de falla de ventrículo derecho, sin descompensación hemodinámica), la relación riesgo-beneficio del tratamiento con trombolíticos es más equilibrada por lo que la decisión es controvertida. La fragmentación mecánica con trombólisis dirigida por catéter es una alternativa con potenciales beneficios. Presentamos dos casos de TEPA de riesgo intermedio, en los que se realizó fragmentación mecánica y trombólisis dirigida por catéter.

Acute pulmonary thromboembolism remains a significant cause of morbidity and mortality worldwide. Its diagnosis, risk stratification and early treatment are essential. The mainstay of treatment is anticoagulation. In patients with low cardiovascular risk, the prognosis is excellent and the treatment consists only of the administration of anticoagulants. Due to the poor prognosis of patients with high risk (hemodynamic decompensation), the approach is more aggressive using systemic thrombolytics, which reduce mortality but increase the risk of major hemorrhagic complications. In the intermediate-risk patients (evidence of right ventricular failure, without hemodynamic decompensation), the risk-benefit relationship of thrombolytic treatment is more balanced, so the choice is controversial. Mechanical fragmentation with catheter-directed thrombolysis is an alternative with potential benefits. We present two cases of intermediate-risk acute pulmonary thromboembolism to whom mechanical fragmentation and catheter-directed thrombolysis was applied.

Concordance and prevalence of subclinical atherosclerosis in different vascular territories.

BACKGROUND: Subclinical atherosclerosis (SA) in the carotid, femoral, and coronary territories is a powerful predictor of cardiovascular (CV) events. Whether it is sufficient to assess SA in a single vascular territory in early-stage disease is uncertain. We aimed to determine the prevalence and concordance of SA in these vascular beds in asymptomatic patients without known CV disease. METHODS: We enrolled patients aged 35 to 75 years who were asymptomatic, without known CV disease, and had undergone carotid and femoral Doppler ultrasonography and calcium scoring. Those receiving statins were excluded. SA was defined as the presence of plaques in the carotid and/or femoral arteries or the presence of calcium in the coronary arteries (Agatston score >0). RESULTS: A total of 212 patients were identified with a mean age of 53 ± 7 years, of which 60% (128 patients) were men. The prevalence of SA was 62%. The distribution of SA between the three territories was similar, involving the carotid territory in 38% of cases, the femoral in 31%, and the coronaries in 37%. The concordance between the different vascular territories was weak, with a k index of 0.21 between the coronary and carotid territories, 0.27 between the coronary and femoral territories, and 0.34 between the carotid and femoral territories. CONCLUSIONS: The prevalence of SA in asymptomatic patients without known CV disease is high. The concordance in the presence of SA between the three vascular territories is weak. Therefore, all three vascular beds need to be investigated.

Left Ventricular Longitudinal Global Strain to Predict Severe Coronary Disease in Patients with Precordial Pain Suggestive of Non-ST-Segment Elevation Acute Coronary Syndrome.

BACKGROUND: Diagnosing non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is not always straightforward. Left ventricular global longitudinal strain (LVGLS) is an echocardiographic method capable of detecting subclinical regional and global ventricular contractile dysfunction due to myocardial ischemia. The objectives of this study were to evaluate the efficacy of LVGLS in diagnosing severe coronary disease in patients with chest pain suggestive of NSTE-ACS and to assess the relationships between LVGLS reduction and ultrasensitive troponin T (UsTnT) elevation, electrocardiographic changes suggestive of ischemia, and the number of vessels with severe obstructions. METHODS: This prospective, observational study evaluated hospitalized patients with chest pain of presumed coronary etiology. All patients underwent electrocardiography (ECG), UsTnT measurement, Doppler echocardiography, LVGLS measurement, and coronary angiography Coronary angiogram (CA) within 48 h of hospitalization. RESULTS: A total of 75 patients with a mean age of 58 ± 17 years were included, of whom 84% (63 patients) were men. An LVGLS value of <-16.5, as determined by the Youden index proved to be useful for the detection of severe coronary obstructions (lesions >70%). The sensitivity, specificity, and positive and negative predictive values were 96%, 88%, 92%, and 92%, respectively. The number of coronary arteries involved had a direct relationship with the degree of LVGLS reduction (P < 0.001). Elevated UsTnT levels occurred more frequently in patients with reduced LVGLS than in those with normal LVGLS (83% vs. 17%, P < 0.0001). Abnormal strain was not associated with electrocardiographic changes suggestive of ischemia. CONCLUSIONS: LVGLS measurement in patients with presumed NSTE-ACS is efficient in predicting the presence of severe coronary disease. The number of coronary arteries involved has a direct relationship with the degree of LVGLS reduction. Abnormal strain is associated with UsTnT elevations but not with electrocardiographic changes suggestive of ischemia.

[Comparison of risk scores to predict subclinical atherosclerosis]. / Comparación de puntajes de riesgo para predecir aterosclerosis subclínica.

Subclinical atherosclerosis is a powerful predictor of cardiovascular events, although it is unknown which of the risk scores is more useful to predict its presence in a Latin American population. The objective was to compare the performance of the risk scores: Framingham, Regicor and Atherosclerotic Cardiovascular Disease Risk Estimator to predict the presence of subclinical atherosclerosis in asymptomatic persons without known cardiovascular disease; as well as determining its prevalence and distribution in the different vascular beds. From 2014 to 2017, patients from 35 to 75 years, asymptomatic and without known cardiovascular disease who underwent a carotid and femoral Doppler echo and calcium score were evaluated. Subclinical atherosclerosis was defined as the presence of plaques in the carotid and/or femoral arteries or the presence of calcium in the coronary arteries (Agatston score > 0). A total of 212 patients were included. The mean age was 53 ± 7 years, of which 60% (128) were male. The prevalence of subclinical atherosclerosis was 62% (131 cases). Of these 131 subjects with a plaque in any of the territories, the Atherosclerotic Cardiovascular Disease Risk Estimator was the one that identified the highest number of cases with high cardiovascular risk (39%), Framingham detected 20%, and Regicor 0% (p < 0.01). The net reclassification was 41%, 50% and 60% respectively (< 0.01). The prevalence of subclinical atherosclerosis in asymptomatic persons without a history of cardiovascular disease was 62%. The Atherosclerotic Cardiovascular Disease Risk Estimator was the most effective predictor of subclinical atherosclerosis in this population.

La aterosclerosis subclínica es un potente predictor de eventos cardiovasculares, aunque se desconoce cuál de los puntajes de riesgo es más eficaz para predecir su presencia en una población latinoamericana. El objetivo fué comparar la performance de los puntajes de riesgo: Framingham, Regicor y Atherosclerotic Cardiovascular Disease Risk Estimator para predecir la existencia de aterosclerosis subclínica en pacientes asintomáticos sin enfermedad cardiovascular conocida; así como determinar la prevalencia y distribución en los distintos lechos vasculares. Desde 2014 a 2017 se evaluaron pacientes de 35 a 75 años asintomáticos y sin enfermedad cardiovascular conocida, a quienes se les realizó una eco Doppler carotídea y femoral, y score de calcio. Se definió como aterosclerosis subclínica a la presencia de placas en las arterias carótidas y/o femorales o a la presencia de calcio en las coronarias (score de Agatston > 0). Se estudiaron así 212 pacientes, edad media 53 ± 7 años, de los cuales el 60% (128) eran varones. La prevalencia de aterosclerosis subclínica fue 62% (131 casos). De esos 131 con placa en alguno de los territorios, el Atherosclerotic Cardiovascular Disease Risk Estimator fue el que identificó el mayor número de casos con riesgo cardiovascular elevado (39%), Framingham detectó 20%, y Regicor 0% (p < 0.01). La reclasificación neta fue del 41%, 50% y 60% respectivamente (< 0.01). La prevalencia de aterosclerosis subclínica en sujetos asintomáticos sin antecedentes de enfermedad cardiovascular fue 62%. El calculador Atherosclerotic Cardiovascular Disease Risk Estimator fue el más efectivo para predecir aterosclerosis subclínica en esta población.

Comparación de puntajes de riesgo para predecir aterosclerosis subclínica / Comparison of risk scores to predict subclinical atherosclerosis

La aterosclerosis subclínica es un potente predictor de eventos cardiovasculares, aunque se desconoce cuál de los puntajes de riesgo es más eficaz para predecir su presencia en una población latinoamericana. El objetivo fué comparar la performance de los puntajes de riesgo: Framingham, Regicor y Atherosclerotic Cardiovascular Disease Risk Estimator para predecir la existencia de aterosclerosis subclínica en pacientes asintomáticos sin enfermedad cardiovascular conocida; así como determinar la prevalencia y distribución en los distintos lechos vasculares. Desde 2014 a 2017 se evaluaron pacientes de 35 a 75 años asintomáticos y sin enfermedad cardiovascular conocida, a quienes se les realizó una eco Doppler carotídea y femoral, y score de calcio. Se definió como aterosclerosis subclínica a la presencia de placas en las arterias carótidas y/o femorales o a la presencia de calcio en las coronarias (score de Agatston > 0). Se estudiaron así 212 pacientes, edad media 53 ± 7 años, de los cuales el 60% (128) eran varones. La prevalencia de aterosclerosis subclínica fue 62% (131 casos). De esos 131 con placa en alguno de los territorios, el Atherosclerotic Cardiovascular Disease Risk Estimator fue el que identificó el mayor número de casos con riesgo cardiovascular elevado (39%), Framingham detectó 20%, y Regicor 0% (p < 0.01). La reclasificación neta fue del 41%, 50% y 60% respectivamente (< 0.01). La prevalencia de aterosclerosis subclínica en sujetos asintomáticos sin antecedentes de enfermedad cardiovascular fue 62%. El calculador Atherosclerotic Cardiovascular Disease Risk Estimator fue el más efectivo para predecir aterosclerosis subclínica en esta población.

Subclinical atherosclerosis is a powerful predictor of cardiovascular events, although it is unknown which of the risk scores is more useful to predict its presence in a Latin American population. The objective was to compare the performance of the risk scores: Framingham, Regicor and Atherosclerotic Cardiovascular Disease Risk Estimator to predict the presence of subclinical atherosclerosis in asymptomatic persons without known cardiovascular disease; as well as determining its prevalence and distribution in the different vascular beds. From 2014 to 2017, patients from 35 to 75 years, asymptomatic and without known cardiovascular disease who underwent a carotid and femoral Doppler echo and calcium score were evaluated. Subclinical atherosclerosis was defined as the presence of plaques in the carotid and/or femoral arteries or the presence of calcium in the coronary arteries (Agatston score > 0). A total of 212 patients were included. The mean age was 53 ± 7 years, of which 60% (128) were male. The prevalence of subclinical atherosclerosis was 62% (131 cases). Of these 131 subjects with a plaque in any of the territories, the Atherosclerotic Cardiovascular Disease Risk Estimator was the one that identified the highest number of cases with high cardiovascular risk (39%), Framingham detected 20%, and Regicor 0% (p < 0.01). The net reclassification was 41%, 50% and 60% respectively (< 0.01). The prevalence of subclinical atherosclerosis in asymptomatic persons without a history of cardiovascular disease was 62%. The Atherosclerotic Cardiovascular Disease Risk Estimator was the most effective predictor of subclinical atherosclerosis in this population.

[Percutaneous balloon angioplasty for treatment of chronic thromboembolic pulmonary hypertension]. / Angioplastia percutánea con balón en hipertensión pulmonar tromboembólica crónica.

Chronic thromboembolic pulmonary hypertension is characterized by the presence of organized thrombotic material in the pulmonary arteries which causes elevation of the pulmonary vascular resistance, right heart failure, and death if not treated. Pulmonary thromboendarterectomy is the treatment of choice and can be curative when the obstruction is proximal. There are cases in which this therapy is not possible, and pulmonary angioplasty is a therapeutic alternative of growing interest. We present our experience with three patients diagnosed with chronic thromboembolic pulmonary hypertension in whom pulmonary endarterectomy was not possible and pulmonary angioplasty was performed. All patients showed improvement of functional class, six-minute walk distance, and hemodynamic as well as angiographic parameters.

Angioplastia percutánea con balón en hipertensión pulmonar tromboembólica crónica / Percutaneous balloon angioplasty for treatment of chronic thromboembolic pulmonary hypertension

La hipertensión pulmonar tromboembólica crónica se caracteriza por la presencia de material trombótico organizado dentro de las arterias pulmonares que genera elevación de la resistencia vascular pulmonar, insuficiencia cardíaca derecha y, eventualmente, la muerte. El tratamiento de elección es la tromboendarterectomía pulmonar, que suele ser curativa si la obstrucción es proximal. En algunos casos este tratamiento no es posible y surge como alternativa la angioplastia pulmonar con balón (APB), que está generando creciente interés. Se presentan tres casos de pacientes con hipertensión pulmonar tromboembólica a los que por diferentes circunstancias no pudo tratarse con tromboendarterectomía y se realizó APB comprobándose, en los tres casos, mejoría de la clase funcional, prueba de la caminata de seis minutos, además de parámetros hemodinámicos y angiográficos.

Chronic thromboembolic pulmonary hypertension is characterized by the presence of organized thrombotic material in the pulmonary arteries which causes elevation of the pulmonary vascular resistance, right heart failure, and death if not treated. Pulmonary thromboendarterectomy is the treatment of choice and can be curative when the obstruction is proximal. There are cases in which this therapy is not possible, and pulmonary angioplasty is a therapeutic alternative of growing interest. We present our experience with three patients diagnosed with chronic thromboembolic pulmonary hypertension in whom pulmonary endarterectomy was not possible and pulmonary angioplasty was performed. All patients showed improvement of functional class, six-minute walk distance, and hemodynamic as well as angiographic parameters.

Efecto de la cafeína sobre la presión arterial y parámetros de la rigidez vascular / Efeito da cafeína na pressão arterial e parâmetros de rigidez vascular / Effect of caffeine on blood pressure and parameters of vascular stiffness

Introducción. La cafeína es una de las sustancias más consumidas mundialmente. Sus efectos fisiológicos han generado preocupación sobre sus potenciales efectos perjudiciales a nivel cardiovascular. Objetivos. Determinar el efecto de dosis habituales de cafeína (50 mg) sobre variables hemodinámicas valoradas con el Mobil-O-GRAPH PWA en sujetos sanos. Evaluar si el tabaquismo exacerba el efecto del café sobre estos parámetros. Materiales y métodos. Estudio prospectivo. Se incluyeron sujetos sanos entre 18 y 55 años, de ambos sexos que debían estar 12 horas libres de cigarrillos o de sustancias con cafeína. Se obtuvieron medidas de parámetros hemodinámicos con el Mobil-O-GRAPH PWA antes y a los 0, 30 y 60 minutos del consumo de 140 mL de café con 50 mg de cafeína. Se evaluó si el tabaquismo exacerba el efecto de la cafeína sobre estos parámetros vasculares. Resultados. Se incluyeron 27 pacientes de los cuales el 45% fue de sexo masculino, con una edad media de 33 ± 9 años. El 29% de los pacientes era tabaquista. A los 60 minutos de la ingesta de café se observó un incremento de 3 mm Hg de la presión arterial media (PAM) que fue significativa (p=0,03). Comparado a los no fumadores, los tabaquistas mostraron un incremento más marcado de la PAM (9 mm Hg vs 2 mm Hg; p=0,05). Los otros parámetros fueron similares en ambos grupos. Conclusión. En sujetos sanos la ingesta de 50 mg de café incrementa la PAM en 3 mm Hg a los 60 minutos y este efecto es más marcado en tabaquistas.

Introduction. Caffeine is one of the most consumed substances worldwide. Its physiological effects have been generated concerns about its potential harmful effects at the cardiovascular level. Objectives. To determine the effect of usual doses of caffeine (50mg) on hemodynamic variables assessed with the Mobil-O-GRAPH PWA in healthy subjects. To assess if smoking exacerbates the effect of coffee on these parameters. Materials and methods. Prospective study. We included healthy subjects between 18 and 55 years of age, of both sexes who had to be 12 hours free of cigarettes or substances with caffeine. Measurements of hemodynamic parameters were obtained with the Mobil-O-GRAPH PWA before and at 0, 30 and 60 minutes of the consumption of 140 mL of coffee with 50 mg of caffeine. It was evaluated if smoking exacerbates the effect of caffeine on these vascular parameters. Results. We included 27 patients of which 45% were male, with a mean age of 33 ± 9 years. The 29% of the patients were smokers. At 60 minutes of coffee intake, an increase of 3 mm Hg in mean arterial pressure (MAP) was observed, which was significant (p = 0.03). Compared to non smokers, smokers showed a more marked increase in MAP (9 mm Hg vs 2 mm Hg, p = 0.05). The other parameters were similar in both groups. Conclusion. In healthy subjects the intake of 50 mg of coffee increases the MAP by 3mmHg at 60 minutes and this effect is more marked in smokers.

Introdução. A cafeína é uma das substâncias mais consumidas no mundo. Seus efeitos fisiológicos geraram preocupação sobre os seus efeitos nocivos potenciais ao nível cardiovascular. Objetivos. Determinar o efeito de doses usuais de cafeína (50mg) nas variáveis hemodinâmicas avaliadas com o Mobil-O-GRAPH PWA em indivíduos saudáveis. Avaliar se o ato de fumar exacerba o efeito do café nesses parâmetros. Materiais e métodos. Estudo prospectivo. Foram incluídos indivíduos saudáveis entre 18 e 55 anos de idade, de ambos os sexos, que deveriam ter 12 horas livres de cigarros ou substâncias com cafeína. As medidas dos parâmetros hemodinâmicos foram obtidas com o Mobil-O-GRAPH PWA antes e aos 0, 30 e 60 minutos do consumo de 140 mL de café com 50 mg de cafeína. Foi avaliado se fumar exacerba o efeito da cafeína sobre esses parâmetros vasculares. Resultados. Foram incluídos 27 pacientes, dos quais 45% eram do sexo masculino, com média de idade de 33 ± 9 anos. O 29% dos pacientes eram fumantes. Aos 60 minutos de ingestão de café, observou-se um aumento de 3 mm Hg na pressão arterial média (PAM), que foi significativo (p=0,03). Em comparação com os não-fumantes, os fumantes apresentaram um aumento mais acentuado da PAM (9 mm Hg vs 2 mm Hg, p=0,05). Os outros parâmetros foram semelhantes nos dois grupos. Conclusão. Em indivíduos saudáveis, a ingestão de 50 mg de café aumenta a PAM em 3 mm Hg aos 60 minutos e esse efeito é mais acentuado nos fumantes.

Clinical practice of ambulatory versus home blood pressure monitoring in hypertensive patients.

OBJECTIVES: This study aimed to analyze whether blood pressure (BP) measurement is concordant between ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), and determine whether the decision on treatment changes is similar on the basis of information provided by both methods. METHODS: Treated hypertensive patients were studied with ABPM and HBPM to evaluate therapeutic efficacy and/or diagnose resistant hypertension (HTN). Modification of pharmacological treatment was decided on the basis of pre-established criteria; therefore, the number of therapeutic changes between both techniques was compared. RESULTS: A total of 200 patients were included. The average daytime ABPM systolic blood pressure (SBP) was 136±16 compared with 136±15 (P=1) with HBPM; the average diurnal diastolic blood pressure (DBP) was 83±12 and 81±9, respectively (P=0.06). The concordance between both methods was very good for SBP [r=0.85; Bland-Altman 0.2 (95% confidence interval 0.9-1.4 mmHg)], and good for the DBP [r=0.77; Bland-Altman 1.8 (95% confidence interval 0.8-2.8 mmHg)]. Both methods were in agreement that HTN was controlled in 68 patients and that it was not controlled in 90 patients, that is, they were concordant in 158 patients (79%, κ=0.6). More patients required changes with ABPM than HBPM (149 vs. 99 patients, P<0.0001) CONCLUSION: There were no significant differences in the measurement of diurnal SBP and DBP between both methods. The concordance to determine proper control of HTN was 79%. There was a significant difference in the decision to modify the treatment in favor of the ABPM.

Relationship between electrocardiographic characteristics of left bundle branch block and echocardiographic findings.

BACKGROUND: Complete left bundle branch block (CLBBB) is an electrocardiographic (ECG) dromotropic disorder seen in patients with various structural heart diseases and sometimes is associated with poor prognosis. Its presence confounds the application of standard ECG criteria for the diagnosis of left ventricular hypertrophy (LVH), myocardial infarction (MI) in the chronic phase, and pathologies that produce changes on ST-T segment. The aim of this investigation was to establish the relationship between CLBBB and cardiac structural abnormalities assessed by echocardiography. METHODS: This observational, cross-sectional study included ECG with CLBBB from 101 patients who also had transthoracic echocardiogram (TTE) performed within 6 months. RESULTS: The prevalence of structural heart disease on TTE was 90%. No ECG criterion was useful to diagnose LVH since no relationship was observed between 9 different ECG signs and increased left ventricular mass index. QRS duration (p = 0.16) and left axis deviation (p = 0.09) were unrelated to reduced left ventricular ejection fraction (LVEF). Eight ECG signs proposed for the diagnosis of the chronic phase of MI demonstrated similar effectiveness, with high specificity and reduced sensitivity. CONCLUSIONS: CLBBB is associated with elevated prevalence of cardiac structural disease and hinders the application of common ECG criteria for the diagnosis of LVH, reduced LVEF, or chronic phase of MI. No ECG finding distinguished patients with structural heart disease from those with normal hearts. Electrocardiographic criteria for the diagnosis of MI in the chronic phase are useful when present, but when absent cannot rule it out.

[Takotsubo Syndrome: experience in three institutions of Cordoba City]. / Síndrome de Takotsubo: experiencia en tres instituciones de la ciudad de Córdoba.

Takotsubo Syndrome is an acquired cardiomyopathy characterized by a transient left ventricular antero-apical asynergy or disynergy (apical ballooning), symptoms and electrocardiographic changes are suggestive of an acute coronary syndrome, moderate cardiac enzymatic release and absence of significant atherosclerotic lesions in coronary arteries. It predominantly affects postmenopausal women and it is frequently preceded by situations of physical or psychological stress. The physiopathology is not completely understood but there is consensus that it is triggered by a surge of catecholamines consequent to the aforementioned stress conditions. The study of 32 cases diagnosed at three medical institutions in Córdoba, Argentina, is reported. The mean age was 61 years, and 28 were female. All cases simulated acute coronary syndromes. Congestive heart failure developed in twelve cases (37.5%) and two patients (6.3%) developed cardiogenic shock. The left ventricular function normalized more rapidly than the electrocardiographic changes. The recurrence rate was 25%, the prognosis was benign considering that only one death occurred following a relapse. In general the findings are similar to previously published studies. Recent advances in the comprehension of the physiopathology of this cardiomyopathy gave way to the development of a rational therapeutic approach.

Síndrome de Takotsubo: experiencia en tres instituciones de la ciudad de Córdoba / Takotsubo Syndrome: experience in three institutions of Cordoba City

Takotsubo es una miocardiopatía adquirida que se caracteriza por la aparición transitoria de acinesia o discinesia antero-apical del ventrículo izquierdo, síntomas y cambios electrocardiográficos que simulan un síndrome coronario agudo, leve elevación de enzimas cardíacas y coronarias sin lesiones ateroscleróticas significativas. Afecta predominantemente a mujeres post menopáusicas y frecuentemente es precedido por situaciones de estrés físico o psicológico. La fisiopatología no ha sido completamente dilucidada pero existe consenso sobre el papel central de la descarga masiva de catecolaminas, secundaria a dichas situaciones de estrés, como mecanismo desencadenante. Se presentan 32 casos diagnosticados en tres instituciones de Córdoba. La edad promedio fue 61 años, el 28 (88%) fueron mujeres, y todos se presentaron simulando síndromes coronarios agudos. Doce pacientes (37.5%) evolucionaron con insuficiencia cardíaca y dos (6%) desarrollaron shock cardiogénico. La función ventricular se normalizó más rápidamente que los cambios electrocardiográficos. La tasa de recurrencia fue del 25%. El pronóstico fue benigno, ya que solo se produjo una muerte como consecuencia de una recidiva. Estos hallazgos son, en general, similares a los publicados en la literatura. También se analizaron recientes progresos sobre la fisiopatología de esta miocardiopatía que permitieron desarrollar un planteo racional de tratamiento.

Takotsubo Syndrome is an acquired cardiomyopathy characterized by a transient left ventricular antero-apical asynergy or disynergy (apical ballooning), symptoms and electrocardiographic changes are suggestive of an acute coronary syndrome, moderate cardiac enzymatic release and absence of significant atherosclerotic lesions in coronary arteries. It predominantly affects postmenopausal women and it is frequently preceded by situations of physical or psychological stress. The physiopathology is not completely understood but there is consensus that it is triggered by a surge of catecholamines consequent to the aforementioned stress conditions. The study of 32 cases diagnosed at three medical institutions in Córdoba, Argentina, is reported. The mean age was 61 years, and 28 were female. All cases simulated acute coronary syndromes. Congestive heart failure developed in twelve cases (37.5%) and two patients (6.3%) developed cardiogenic shock. The left ventricular function normalized more rapidly than the electrocardiographic changes. The recurrence rate was 25%, the prognosis was benign considering that only one death occurred following a relapse. In general the findings are similar to previously published studies. Recent advances in the comprehension of the physiopathology of this cardiomyopathy gave way to the development of a rational therapeutic approach.

Síndrome de Takotsubo: experiencia en tres instituciones de la ciudad de Córdoba / Takotsubo Syndrome: experience in three institutions of Cordoba City

Takotsubo es una miocardiopatía adquirida que se caracteriza por la aparición transitoria de acinesia o discinesia antero-apical del ventrículo izquierdo, síntomas y cambios electrocardiográficos que simulan un síndrome coronario agudo, leve elevación de enzimas cardíacas y coronarias sin lesiones ateroscleróticas significativas. Afecta predominantemente a mujeres post menopáusicas y frecuentemente es precedido por situaciones de estrés físico o psicológico. La fisiopatología no ha sido completamente dilucidada pero existe consenso sobre el papel central de la descarga masiva de catecolaminas, secundaria a dichas situaciones de estrés, como mecanismo desencadenante. Se presentan 32 casos diagnosticados en tres instituciones de Córdoba. La edad promedio fue 61 años, el 28 (88%) fueron mujeres, y todos se presentaron simulando síndromes coronarios agudos. Doce pacientes (37.5%) evolucionaron con insuficiencia cardíaca y dos (6%) desarrollaron shock cardiogénico. La función ventricular se normalizó más rápidamente que los cambios electrocardiográficos. La tasa de recurrencia fue del 25%. El pronóstico fue benigno, ya que solo se produjo una muerte como consecuencia de una recidiva. Estos hallazgos son, en general, similares a los publicados en la literatura. También se analizaron recientes progresos sobre la fisiopatología de esta miocardiopatía que permitieron desarrollar un planteo racional de tratamiento.(AU)

Takotsubo Syndrome is an acquired cardiomyopathy characterized by a transient left ventricular antero-apical asynergy or disynergy (apical ballooning), symptoms and electrocardiographic changes are suggestive of an acute coronary syndrome, moderate cardiac enzymatic release and absence of significant atherosclerotic lesions in coronary arteries. It predominantly affects postmenopausal women and it is frequently preceded by situations of physical or psychological stress. The physiopathology is not completely understood but there is consensus that it is triggered by a surge of catecholamines consequent to the aforementioned stress conditions. The study of 32 cases diagnosed at three medical institutions in Córdoba, Argentina, is reported. The mean age was 61 years, and 28 were female. All cases simulated acute coronary syndromes. Congestive heart failure developed in twelve cases (37.5%) and two patients (6.3%) developed cardiogenic shock. The left ventricular function normalized more rapidly than the electrocardiographic changes. The recurrence rate was 25%, the prognosis was benign considering that only one death occurred following a relapse. In general the findings are similar to previously published studies. Recent advances in the comprehension of the physiopathology of this cardiomyopathy gave way to the development of a rational therapeutic approach.(AU)

Síndrome de Takotsubo: experiencia en tres instituciones de la ciudad de Córdoba. / [Takotsubo Syndrome: experience in three institutions of Cordoba City].

Takotsubo Syndrome is an acquired cardiomyopathy characterized by a transient left ventricular antero-apical asynergy or disynergy (apical ballooning), symptoms and electrocardiographic changes are suggestive of an acute coronary syndrome, moderate cardiac enzymatic release and absence of significant atherosclerotic lesions in coronary arteries. It predominantly affects postmenopausal women and it is frequently preceded by situations of physical or psychological stress. The physiopathology is not completely understood but there is consensus that it is triggered by a surge of catecholamines consequent to the aforementioned stress conditions. The study of 32 cases diagnosed at three medical institutions in Córdoba, Argentina, is reported. The mean age was 61 years, and 28 were female. All cases simulated acute coronary syndromes. Congestive heart failure developed in twelve cases (37.5

) and two patients (6.3

) developed cardiogenic shock. The left ventricular function normalized more rapidly than the electrocardiographic changes. The recurrence rate was 25

, the prognosis was benign considering that only one death occurred following a relapse. In general the findings are similar to previously published studies. Recent advances in the comprehension of the physiopathology of this cardiomyopathy gave way to the development of a rational therapeutic approach.

[Post-traumatic false (pseudo) aneurysm of the left main coronary artery]. / Pseudo aneurisma post-traumático de tronco de arteria coronaria izquierda.

Coronary pseudo-aneurysm is an extremely rare entity. Its natural history is scarcely known and its treatment is controversial. We report a case of pseudo-aneurysm of the left main coronary artery associated with an antero-apical infarct of the left ventricle diagnosed five years after a cardiac arrest following a non-penetrating thoracic trauma. The patient was treated conservatively because percutaneous or surgical correction were not considered suitable for this lesion. A multidetector computed tomography coronary angiogram performed 10 years after the initial event showed no evidence of progression.

Pseudo-aneurisma post-traumático de tronco de arteria coronaria izquierda / Post-traumatic false (pseudo) aneurysm of the left main coronary artery

El pseudo-aneurisma de arteria coronaria es extremadamente raro. Su historia natural es poco conocida y su tratamiento discutido. Se presenta el caso de un paciente con pseudo-aneurisma de tronco de la coronaria izquierda e infarto antero-apical del ventrículo izquierdo cinco años después de un paro cardíaco secundario a un traumatismo no penetrante de tórax. Se consideró entonces que la lesión no era pasible de corrección percutánea o quirúrgica por lo que se optó por tratamiento médico conservador. Una angiografía coronaria por tomografía computarizada multicorte realizada 10 años después del evento inicial mostró ausencia de progresión de la lesión.

Coronary pseudo-aneurysm is an extremely rare entity. Its natural history is scarcely known and its treatment is controversial. We report a case of pseudo-aneurysm of the left main coronary artery associated with an antero-apical infarct of the left ventricle diagnosed five years after a cardiac arrest following a non-penetrating thoracic trauma. The patient was treated conservatively because percutaneous or surgical correction were not considered suitable for this lesion. A multidetector computed tomography coronary angiogram performed 10 years after the initial event showed no evidence of progression.

Arrhythmias in a patient with sarcoidosis.

Arrhythmias in a Patient With Sarcoidosis. Sarcoidosis is a multisystemic granulomatous disease of unknown etiology; up to 27% of cases entail cardiac involvement. Conduction abnormalities and ventricular tachycardia are the most common arrhythmias and can cause sudden death. We describe a patient who developed cardiac sarcoidosis 9 years after undergoing surgery for neurosarcoidosis. He presented with 2:1 second-degree atrioventricular block. Ventricular tachycardia with 3 morphologies was induced by exercise stress test. A DDD pacer/implantable cardioverter defibrillator (ICD) was implanted, which prevented exercise-induced ventricular tachycardia in a follow-up stress test. Treatment with steroids was initiated. The AVB disappeared, and no further arrhythmias were documented at the 1-year follow-up.

Multicenter randomized comparison of direct vs. conventional stenting: the DIRECTO trial.

With conventional stenting, predilatation frequently induces dissections that require deploying stents longer than originally planned. To assess whether direct stenting is safe and may prevent dissections and reduce the length of stents implanted, we conducted a randomized study comparing direct (n = 73) and conventional (n = 78) stenting. Direct stenting was successful in 89% of cases, 11% crossed over to predilation without complications. Dissections occurred more frequently in conventional stenting group (10.3% vs. 1.4%; P = 0.034), but did not translate to a significant stent length difference (16.31 +/- 7.6 vs. 15.31 +/- 5.5; P = NS). Periprocedure creatine kinase elevation and number of balloons utilized were lower with direct stenting.

Clinical features of hypertrophic cardiomyopathy in the young.

BACKGROUND: We analysed the experience with hypertrophic cardiomyopathy in two paediatric centres to establish the differences from older patients. METHODS: Out of 45 young patients seen from 1974 to 1999, we included 38. Criterions for exclusion were secondary forms, or association with severe congenital cardiac disease which could alter the outcome. RESULTS: The patients presented at the age of 5.7 years, and were followed for 7.0 years. The 34 patients referred because of a murmur or cardiomegaly were older than the four with heart failure, presenting at 6.2 as opposed to 2.1 years of age, p = 0.08. Of the patients, 29 (76%) had primary cardiomyopathy, while 9 (24%) had secondary forms associated with Noonan's and LEOPARD syndromes. Familial tendency was ascertained in 7 patients (18%). The septal thickness in mm/m2 at presentation was greater in patients under 2 years than in older children (29 vs 18, p = 0.02). Obstructive hypertrophic cardiomyopathy was found in 17 patients (45%), with six of these having mild associated congenital cardiac defects. Nine had symptomatic arrhythmias. Overall, treatment was medical in 31, with DDD pacing used in 5, and surgery, radiofrequency ablation, and transplantation in one patient each. Total mortality was 24%, at a rate of 4.3% per year. Four patients died in heart failure and 5 had sudden death. Those in failure were significantly younger (p = 0.01). CONCLUSIONS: Hypertrophic cardiomyopathy in the young is characterized by referral for murmur or heart failure; frequent secondary forms; the obstructive variant being as common as the non-obstructive form; a mortality rate similar to that for adults attending tertiary centres; and less frequent familial forms than in older populations.